Details for: RPL19P9

Gene ID: 653314

Gene Type:  Pseudogene  - A non-functional segment of DNA that resembles a functional gene but has lost its protein-coding ability or is otherwise no longer expressed.

Symbol: RPL19P9

Ensembl ID: ENSG00000218227

Description: ribosomal protein L19 pseudogene 9

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 15.65
    rCSI 12.54%
    PRS 99.66
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 11.99
    rCSI 18.69%
    PRS 99.83

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary Analyzed for its expression specificity (CSI Z-Score), [RPL19P9](/details-gene/653314) is a pseudogene whose expression appears highly restricted to T-cell precursors in the thymus. The data from the **Overall** context shows that its transcripts are almost exclusively detected in [CD4-positive, alpha-beta thymocyte](/details-cell/CL0000810) and [CD8-positive, alpha-beta thymocyte](/details-cell/CL0000811). However, this finding is accompanied by conflicting statistical metrics; while the effect size is maximal (1.00), indicating high exclusivity, the Z-score is 0.00 and the result is not statistically significant (p > 0.4). This suggests that while its expression pattern is highly cell-type specific, the transcript levels may be too low or variable to be confidently distinguished from baseline noise in this analysis, warranting further investigation into its potential regulatory role during thymocyte development. ## Cellular Roles and Expression Landscape The primary role of [RPL19P9](/details-gene/653314) as suggested by this specificity-focused analysis (CSI Z-SCORE) is one of high cellular restriction rather than high abundance. The gene's expression is narrowly confined to developing T-cells, specifically [CD4-positive, alpha-beta thymocyte](/details-cell/CL0000810) and [CD8-positive, alpha-beta thymocyte](/details-cell/CL0000811). This is strongly supported by a perfect Effect Size (deltaVal) of 1.00 for both cell types, which signifies that its expression is, within the limits of detection, exclusive to these cells compared to all other cell populations surveyed. Despite this strong signal of exclusivity, the associated statistical confidence is low. The CSI (Z-SCORE) of 0.00 indicates a lack of significant deviation from the mean expression across all cell types, and the high p-values (p ≈ 0.5) suggest the observed pattern could be due to chance. This unusual combination of high exclusivity and low statistical significance may arise if the gene's absolute expression level is very low or exhibits high variance among cells. Therefore, while [RPL19P9](/details-gene/653314) is not a robust statistical marker of specificity in this dataset, its highly restricted expression pattern points toward a potential, albeit perhaps subtle, function specifically within the thymic environment during T-cell maturation. ## Pathways and Molecular Function As a pseudogene, [RPL19P9](/details-gene/653314) is not presumed to be translated into a functional protein. Its potential function is more likely to be regulatory, acting as a non-coding RNA. It is derived from the gene encoding Ribosomal Protein L19 (RPL19), a component of the 60S ribosomal subunit essential for protein synthesis. Beyond this canonical role, RPL19 has been implicated in extra-ribosomal functions, including the regulation of cell proliferation and apoptosis, often through interactions with the p53 pathway ([Daftuar et al., *Cell Death Dis*, 2013, doi: 10.1038/cddis.2013.71](https://doi.org/10.1038/cddis.2013.71)). Given that thymocytes undergo rigorous selection processes involving massive proliferation and apoptosis, the specific expression of a pseudogene related to RPL19 in this context is notable. [RPL19P9](/details-gene/653314) could potentially regulate the expression of its parent gene, [RPL19], or other related transcripts. For instance, it might function as a competing endogenous RNA (ceRNA), sequestering microRNAs that would otherwise target [RPL19] or other genes involved in controlling the fine balance between survival and apoptosis during T-cell development. ## Research Directions The intriguing, albeit statistically ambiguous, expression pattern of [RPL19P9](/details-gene/653314) in thymocytes provides a foundation for several novel lines of inquiry. The central challenge is to validate this expression and determine if it represents a biological function or a transcriptional artifact. ### Testable Hypotheses: 1. **[RPL19P9](/details-gene/653314) functions as a ceRNA to regulate [RPL19] expression and modulate thymocyte proliferation.** The pseudogene could act as a sponge for microRNAs targeting its parent gene, thereby fine-tuning the levels of ribosomal protein L19, which is critical for the rapid protein synthesis required during T-cell proliferation. * **Experimental Approach:** Utilize CRISPRi to specifically repress [RPL19P9](/details-gene/653314) in a human thymocyte cell line. Assess the impact on [RPL19] mRNA and protein levels via qRT-PCR and Western blot. Concurrently, perform cell proliferation assays (e.g., Ki-67 staining) to determine the functional consequence of its knockdown. 2. **The expression of [RPL19P9](/details-gene/653314) is dynamically regulated during thymic selection and contributes to apoptosis control.** Its specific expression in thymocytes suggests it may be involved in the life-or-death decisions of positive and negative selection, potentially by modulating the known pro-apoptotic functions of its parent gene. * **Experimental Approach:** Sort primary human thymocytes into developmental subsets (double-negative, double-positive, single-positive) and quantify [RPL19P9](/details-gene/653314) expression. Induce apoptosis using dexamethasone or TCR signaling and measure how [RPL19P9](/details-gene/653314) levels change, and how its overexpression or knockdown affects cellular sensitivity to these apoptotic stimuli. 3. **The detected [RPL19P9](/details-gene/653314) signal is a result of transcriptional noise or a cross-mapping artifact from the highly expressed parent [RPL19] gene.** The lack of statistical significance (high p-value) in the current dataset lends credence to the possibility that the signal is not biologically meaningful. * **Experimental Approach:** Design and validate highly specific primers that exclusively amplify [RPL19P9](/details-gene/653314) without detecting [RPL19]. Use these for absolute quantification with droplet digital PCR (ddPCR) on sorted thymocytes. Further confirmation could be achieved with single-molecule fluorescence in situ hybridization (smFISH) to visualize and count individual [RPL19P9](/details-gene/653314) transcripts within single thymocytes, confirming its existence and subcellular localization. ### Therapeutic Potential: If [RPL19P9](/details-gene/653314) is confirmed to have a functional role in thymocyte development or apoptosis, its high cell-type specificity would make it an attractive therapeutic target. For conditions involving aberrant T-cell development, such as T-cell acute lymphoblastic leukemia (T-ALL) or certain autoimmune diseases, modulating the activity of [RPL19P9](/details-gene/653314) with targeted antisense oligonucleotides could offer a precise way to manipulate T-cell fate with minimal off-target effects. However, any therapeutic consideration is highly speculative and entirely dependent on first validating its expression and elucidating its molecular function.